Twenty-six previously untreated children, median age 3.4 years, with pelvic rhabdomyosarcoma (RMS) were seen between 1983 and 1988. Fourteen were girls. The planned strategy was to conserve pelvic organs, especially the bladder, by using primary chemotherapy, conservative surgery and, in most cases, radiotherapy. With a median follow-up of 71 months (range 34-103 months) overall survival was 73%, with no treatment-related death. The bladder salvage rate of 88% in survivors with bladder base,prostate primaries was much higher than that reported by the United States Intergoup Rhabdomyosarcoma Studies (IRS), though many of the preserved bladders did not function normally. We identified problems with both radiological and histological off-treatment monitoring. The overall accuracy of computerised tomographic (CT') scanning for prediction of tumour recurrence was only 81%, and endoscopic biopsies proved misleading in four of the ten bladder base/prostate patients monitored by serial cystoscopy. We conclude that a higher cure rate can be achieved by using intensive chemotherapy/radiotherapy and conservative surgery to treat children with pelvic RMS. Factors that might contribute to our favourable bladder salvage results, compared with those of the IRS, include (a) the fact that one of two specialist surgeons monitored and operated on all these patients and (b) our increasing awareness, during the study, that post-chemotherapy, radiotherapy histopathology and pelvic CT scan appearances may be misleading. Referral to paediatric centres with special experience of pelvic RMS may help raise the rate of bladder salvage in these children.
The cure rate for pelvic rhabdomyosarcoma in children is now approximately 70%, although survival depends on the tumour stage at diagnosis and the exact site of origin within the pelvis (Flamant et al., 1990; Raney et al., 1990) . Primary tumours are not always controlled by established treatment regimens, and some children die from local regrowth of tumour with or without disseminated disease. Despite this difficulty with 'local control', most treatment teams now try to limit the morbidity of surgery. Total cystectomy cystoprostatectomy, which results in loss of bladder and sexual function, may be avoided in some children by performing surgery after several months of chemotherapy. The 'shrunken' tumour may then be resectable without ablating pelvic organs and radiotherapy used to treat any residual disease. Only 11 of 20 children with pelvic rhabdomyosarcoma treated at this hospital with chemotherapy, radiotherapy and surgery between 1976 and 1983 survived, and only six retained their bladders (Broecker et al., 1988) . After 1983, we formally adopted a conservative surgical policy to try to spare children total cystoprostatectomy or total cystectomy.
The main aim of this study was to assess the results of multimodal therapy, including this conservative surgical policy, in a paediatric hospital with close liaison between paediatric oncologists, urologists, histopathologists and radiologists. Supplementary aims were to determine the value of serial computerised tomographic (CT) hospital between 1983 and 1988 (Table I ). In five cases surgical resection, not involving ablation of pelvic viscera, had been attempted elsewhere but none of the children had received chemotherapy or radiotherapy. Age at presentation ranged from 3 months to 14.9 years (median 3.4 years) and 14 patients were girls.
The exact sites of the primary tumours were: bladder base/prostate (13 patients), bladder dome (3), uterus/vagina (5) and pelvic wall (5). Initial investigations included posteroantenor and lateral chest radiographs, abdominal ultrasound, CT scanning of chest and pelvis, radioisotope bone scan and bilateral iliac bone marrow aspiration. These studies indicated that 22 patients had group 3 disease (unresectable local tumour), two group 4 and one each group I and 2. In the case of 'endophytic' tumours of the bladder, prostate and vagina accessible by endoscopy, examination under anaesthetic and biopsies were carried out by one of the two surgeons (P.G.R. and P.G.D.) involved in the study. Histological subtypes were embryonal (24) and alveolar (2).
Reassessments involved sequential contrast-enhanced CT scans of the pelvis and examinations under anaesthesia with cystoscopy and endoscopic biopsies at 3 monthly intervals during treatment and for 2 years from completion of treatment. Thereafter, the same examinations were carried out less frequently for up to 5 years from completion of treatment. Patients have been followed till their death or till July 1993. None has been lost to follow-up.
Treatment Policy
After initial radiological assessment, endoscopy and biopsy diagnosis, chemotherapy was commenced. Different chemotherapy schedules were used, according to the trial current at the time each child was diagnosed (Table II) . The timing and type of surgery depended on the exact site of the tumour and the initial response to chemotherapy. Radiotherapy was used either to treat microscopic post-surgical disease or as the sole local modality in cases where, in the opinion of the surgeon, an adequate resection could not be carried out without ablative surgery. More chemotherapy (9-12 months overall Table   I. duration) was used to treat residual disease following surgery and/or radiotherapy.
As far as 'local tumour control' is concered, our approach was as follows. Three operative techniques were used to remove bladder tumours to try to avoid total cystectomy. These were (a) partial cystectomy, (b) submucosal resection for intravesical lesions and (c) resection of tumour masses adherent to the bladder or prostate without partial cystectomy. Total cystectomy with external diversion was used only as 'salvage therapy' for intravesical or bladder base/prostate recurrence after failure of local control by chemotherapy, radiotherapy and previous conservative surgery. The type and total dose of radiotherapy ( Chemotherapy consisted of sequential 3 weekly courses of (a) vincristine, actinomycin D and cyclophosphamide ('VAC`or 'intensive VAC') (nine patients) or (b) ifosfamide, vincristine and actinomycin D ('IVA') (ten patients) or (c) altemating 'VAC/EVD' (etoposide, vincristine and doxorubicin) (five patients). One patient received EVD alone. Courses were given every 3 weeks, or as soon afterwards as possible. Total duration of chemotherapy was 26-40 weeks. During radiotherapy, only weekly vincristine was given. "One child (see text) received only palliative treatment (no chemotherapy).
Sixteen children with tumours of the bladder base/prostate (11), uterus and vagina (3) and pelvic wall (2) had primary chemotherapy then local surgical resections. Of the 11 with bladder base/prostate primaries (Figure 2 ), two finally underwent total cystectomy with external diversion after radiotherapy had apparently failed to eradicate microscopic residual disease. One of these children died later after (Yeung et al., 1994) . The numbers of the children in Yeung's study are indicated in parenthesis in (81%) of these comparisons. In 5/10 instances of disagreement, CT sug that tumour was present but this was not confirmed by surgery or biopsy and none of these patients has relapsed. In the five other cases there was no evidence of tumour on CT but tumour, thought to be present at surgery, was confirmed on histological xaminaton.
Among the ten patients with bladder base/prostate lesions who achieved complete radiological remission, serial biopsies proved misleading in four. Apparently viable 'rhabdomyoblasts' were present in biopsies from three patients who have not relapsed, despite having no further treatment from 11 to 65 months (median 48 months) since the biopsy. The fourth child (already mentioned) underwent total cystoprostatectomy but no tumour was found in the resected specumen.
Poor control of systemic disease by chemotherapy was the main reason for treatment failure. A variety of chemotherapy regimens were used depending upon the protocol in use at the time of diagnosis. Because of the small number of children in each subgroup, no comment on their relative efficacy can be made, and this discussion focuses on the impact of 'local' therapy (conservative surgery and radiotherapy) on treatment outcome. Our findings indicate that preservation of the bladder has not prejudiced the overall cure rate, though it is possible that the one patient who died of local disease might have benefited from earlier anterior exenteration.
There were eight treatment failures. Two patients, one with a bladder base/prostate tumour and one with a pelvic wall primary and extensive regional spread, did not achieve complete remission; both died with uncontroled local disease. Six patients relapsed after apparent complete response. The four children with metastases all died, but two boys with only a local recurrence were 'salvaged' with further chemotherapy or radiotherapy and cystoprostatectomy.
Because of the small numbers of patients in this series, differences in outcome for the different primary sites of tumour cannot be compared for statistical signifi , but three of five patients with pelvic wall tumours presented with either metastases or extensive local/regional disease and died, and a fourth child soon relapsed with metastases. Larger numbers would be needed to examine the possibility that children with primary tumours at this site present 'late' and have a relatively poor prognosis; those chiklden with bladder and genital tract tumours tend to present with urinary symptoms and bleeding, possibly at an earlier stage (Maurer et al., 1993) . Primary tumours of the bladder dome are especially amenable to surgical excision (Hays et al., 1990) , and all three children in our study survive with good bladder function.
There is considerable morbidity among the other survivors with preserved bladders, probably the consequence of loss of functional bladder volume and sphincter damage (Yeung et al., 1994 (Mclorie et al., 1989 (Husband et al., 1989) . Ultrasound may be useful in the assessment of small residual masses and, as has been demonstrated in adults, transrectal probes provide good images of the prostate region (Brooman et al., 1981) .
However, neither MRI nor ultrasound was ased in this study.
Our study highlights a problem in the managemt of patients who, after completion of chemotherapy and/or radiotherapy, have rhabdomyoblast-like cells in endoscopic biopsies, without macroscopic evidence of recurrence. In four patients rhabdomyoblasts were present in biopsies from previously involved areas of the bladder and/or bladder neck, though no macroscopic tumour was visible at the time of biopsy. As no residual tumour was present in the resected total cystoprostatectomy specimen of the first of these patients, no additional treatment was given to the other three childrn and, after a median follow-up of 48 months from biopsy, none of these patient has had tumour recurrence. This indicates that the presence of apparently viable rhabdomyoblasts in a small biopsy specimen is not necessarily an indicator of biologically malignant behaviour.
Our 'bladder salvage' rate is now much better than it was in the 1970s and early 1980s (Flamant et al., 1990 ) and (albeit with small numbers) superior to that of the IRS I and II studies (Maurer et al., 1988; Mclone et al., 1989; Hays et al., 1990; Maurer et al., 1993) . We accept that the preserved bladder may have impaired fumction and that reconstruction may be required, but our results encourage us to try to refine our current surgical conservative treatment approach rather than revert to a policy of early cystectomy/cystoprostatectomy. The close collaboration that develops between a team in a single institution, such as ours, when dealing with these patients is probably crucial. We suggest that organ preservation, with 'acceptable' function, with or without reconstructive surgery, may be an achievable goal if patients are referred to specialised centres where experience in and resources for the management of this uncommon condition are concentrated.
Six of the seven children in this series who died had uncontrollable metastatic disease, so it is evident that better chemotherapy is needed (Womer, 1993) . Possibilities currently under investigation, are (a) that ifosphamide might be superior to cyclophosphamide (the 'IVA' regime rather than 'VAC') , (b) that multidrug resistance (Chan et al., 1990) might be reversed by cyclosporin or verapamil and that (c) use of 'continuous' chemotherapy, especially etoposide, might be more effective than 'pulsed' administration. Improvement in the control of systemic disease would almost certainly also boost the 'local control' rate and allow more children to complete treatment with intact, and possibly non-irradiated, pelvic organs.
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